{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:29:12Z","timestamp":1779884952363,"version":"3.53.1"},"reference-count":125,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>The association of frailty with body composition is complex. Frailty can be associated with significant anorexia and weight loss or overweight and obesity. In addition, the development of frailty leads to changes in muscle mass, muscle fibre type, and visceral fat. In older people with diabetes, frailty-induced body composition changes are clinically relevant as they may affect the metabolic profile of the frail person. The determinants of insulin resistance in frail older persons with diabetes include factors such as total body weight and the ratio of lean muscle mass to visceral fat mass. The predominant loss of insulin-resistant skeletal muscle fibres type II, in comparison to insulin-sensitive type I fibres, is another factor that modifies the overall insulin resistance of the individual. As a result, frailty appears to be a heterogeneous condition with variable insulin resistance across a metabolic spectrum. The spectrum spans from a sarcopenic obese frail phenotype at one end to an anorexic malnourished frail phenotype at the other end. The introduction of SGLT-2 inhibitors and GLP-1RA with novel anti-metabolic syndrome properties, not just glucose-lowering effect, should influence clinicians\u2019 choice in frail older persons with diabetes. These agents are likely to be beneficial in patients at the sarcopenic obese end of the frailty spectrum, who should benefit most due to their high baseline risk of progression of metabolic syndrome, high insulin resistance, and the increased prevalence of cardiovascular risk factors. On the other hand, patients at the anorexic malnourished end of the frailty spectrum are likely not suitable for such therapy due to the regression of metabolic syndrome in this group of patients and the increased risk of further weight loss, dehydration, and hypotension.<\/jats:p>","DOI":"10.3390\/metabo15060381","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:54:05Z","timestamp":1749448445000},"page":"381","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes"],"prefix":"10.3390","volume":"15","author":[{"given":"Alan","family":"Sinclair","sequence":"first","affiliation":[{"name":"King\u2019s College, London WC2R 2LS, UK"},{"name":"Foundation for Diabetes Research in Older People (fDROP), Droitwich Spa WR9 0QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izel","family":"Siqueira","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Rotherham General Hospital, Moorgate Road, Rotherham S60 2UD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelhafiz","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Rotherham General Hospital, Moorgate Road, Rotherham S60 2UD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jdiacomp.2017.05.003","article-title":"Frailty and sarcopenia\u2014Newly emerging and high impact complications of diabetes","volume":"31","author":"Sinclair","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chhetri, J.K., Zheng, Z., Xu, X., Ma, C., and Chan, P. (2017). The prevalence and incidence of frailty in pre-diabetic and diabetic community dwelling older population: Results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0439-y"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.annepidem.2018.04.009","article-title":"Frailty and diabetes among Mexican American older adults","volume":"28","author":"Howrey","year":"2018","journal-title":"Ann. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40520-017-0852-2","article-title":"Frailty, diabetes, and the convergence of chronic disease in an age-related condition: A population-based nationwide cross-sectional analysis of the Mexican nutrition and health survey","volume":"30","author":"Cesari","year":"2018","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_6","first-page":"162","article-title":"The Emergence of Frailty May Lead to a State of Burnt Out Type 2 Diabetes","volume":"5","author":"Abdelhafiz","year":"2016","journal-title":"J. Frailty Aging"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 13. Older Adults: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S266\u2013S282.","DOI":"10.2337\/dc25-S013"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"a029785","DOI":"10.1101\/cshperspect.a029785","article-title":"Effects of exercise and aging on skeletal muscle","volume":"8","author":"Distefano","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3904\/kjim.2016.193","article-title":"Sarcopenia and sarcopenic obesity","volume":"31","author":"Choi","year":"2016","journal-title":"Korean J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ajcn\/76.2.473","article-title":"Longitudinal changes in body composition in older men and women: Role of body weight change and physical activity","volume":"76","author":"Hughes","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.exger.2007.03.003","article-title":"Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms","volume":"42","author":"Cartwright","year":"2007","journal-title":"Exp. Gerontol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1038\/s41467-021-24956-2","article-title":"Impact of aging and exercise on skeletal muscle mitochondrial capacity, energy metabolism, and physical function","volume":"12","author":"Grevendonk","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e158451","DOI":"10.1172\/JCI158451","article-title":"Metabolic changes in aging humans: Current evidence and therapeutic strategies","volume":"132","author":"Palmer","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2337\/diaspect.17.3.183","article-title":"Glucose Metabolism and Regulation: Beyond Insulin and Glucagon","volume":"17","author":"Aronoff","year":"2004","journal-title":"Diabetes Spectr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/dc07-1443","article-title":"Effect of aging on glucose homeostasis: Accelerated deterioration of \u03b2-cell function in individuals with impaired glucose tolerance","volume":"31","author":"Szoke","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/pr.108.000604","article-title":"The Role of Incretins in Glucose Homeostasis and Diabetes Treatment","volume":"60","author":"Kim","year":"2008","journal-title":"Pharm. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1210\/en.2003-0323","article-title":"Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets","volume":"144","author":"Farilla","year":"2003","journal-title":"Endocrinology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/diabetes.52.7.1738","article-title":"Mechanisms of the age-associated deterioration in glucose tolerance: Contribution of alterations in insulin secretion, action, and clearance","volume":"52","author":"Basu","year":"2003","journal-title":"Diabetes"},{"key":"ref_20","first-page":"731","article-title":"Frailty: An emerging research and clinical paradigm-issues and controversies","volume":"62A","author":"Bergman","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1532-5415.2006.00745.x","article-title":"Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society\/National Institute on Aging Research Conference on Frailty in Older Adults","volume":"54","author":"Walston","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_22","first-page":"925","article-title":"Diabetes mellitus, hypertension and frailty: A population-based, cross-sectional study of Mexican older adults","volume":"17","author":"Cesari","year":"2016","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/ggi.12910","article-title":"Relationship between chronic kidney disease with diabetes or hypertension and frailty in community-dwelling Japanese older adults","volume":"17","author":"Lee","year":"2016","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1532-5415.2011.03472.x","article-title":"Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus","volume":"59","author":"Lee","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1532-5415.2005.53300.x","article-title":"The association between obesity and the frailty syndrome in older women: The Women\u2019s Health and Aging Studies","volume":"53","author":"Blaum","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jayanama, K., Theou, O., Godin, J., Mayo, A., Cahill, L., and Rockwood, K. (2022). Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults. BMC Med., 20.","DOI":"10.1186\/s12916-022-02596-7"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wang, Y., Shen, S., Han, P., Zheng, K., Chen, C., Wu, Y., Huang, C., Guo, J., Qi, Y., and Chen, X. (2024). The association between visceral fat obesity and prefrailty in Chinese older adults: A cross-sectional study. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-024-01625-1"},{"key":"ref_30","first-page":"1299","article-title":"Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease","volume":"86","author":"Xu","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/ageing\/afab039","article-title":"Abdominal obesity, body mass index and the risk of frailty in community-dwelling older adults: A systematic review and meta-analysis","volume":"50","author":"Yuan","year":"2021","journal-title":"Age Ageing"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nutres.2020.10.009","article-title":"Frailty status is related to general and abdominal obesity in older adults","volume":"85","author":"Alfonso","year":"2021","journal-title":"Nutr. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e065707","DOI":"10.1136\/bmjopen-2022-065707","article-title":"Body mass index, waist circumference and pre-frailty\/frailty: The Troms\u00f8 study 1994\u20132016","volume":"13","author":"Uchai","year":"2023","journal-title":"BMJ Open"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-009-0947-5","article-title":"Osteoporosis and gait and balance disturbances in older sarcopenic obese New Zealanders","volume":"21","author":"Waters","year":"2010","journal-title":"Osteoporos. Int."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Liang, H., Li, X., Lin, X., Ju, Y., and Leng, J. (2021). The correlation between nutrition and frailty and the receiver operating characteristic curve of different nutritional indexes for frailty. BMC Geriatr., 21.","DOI":"10.1186\/s12877-021-02580-5"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.maturitas.2016.04.009","article-title":"The relationship between nutrition and frailty: Effects of protein intake, nutritional supplementation, vitamin D and exercise on muscle metabolism in the elderly. A systematic review","volume":"93","author":"Malafarina","year":"2016","journal-title":"Maturitas"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.clnu.2018.11.021","article-title":"Muscle loss: The new malnutrition challenge in clinical practice","volume":"38","author":"Landi","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MCO.0000000000000336","article-title":"Anorexia of aging and its role for frailty","volume":"20","author":"Sanford","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cox, N.J., Ibrahim, K., Sayer, A.A., Robinson, S.M., and Roberts, H.C. (2019). Assessment and Treatment of the Anorexia of Aging: A Systematic Review. Nutrients, 11.","DOI":"10.3390\/nu11010144"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MCO.0b013e328359efd7","article-title":"Pathophysiology of the anorexia of aging","volume":"16","author":"Morley","year":"2013","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/appe.1993.1044","article-title":"Age-related changes in spontaneous food intake and hunger in humans","volume":"21","year":"1993","journal-title":"Appetite"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Calvani, R., Martone, A.M., Marzetti, E., Onder, G., Savera, G., Lorenzi, M., Serafini, E., Bernabei, R., and Landi, F. (2014). Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patients. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00269"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/gerona\/glp186","article-title":"Frailty, body mass index, and abdominal obesity in older people","volume":"65","author":"Hubbard","year":"2010","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Watanabe, D., Yoshida, T., Watanabe, Y., Yamada, Y., Kimura, M., and Kyoto-Kameoka Study Group (2020). A U-Shaped Relationship between the Prevalence of Frailty and Body Mass Index in Community-Dwelling Japanese Older Adults: The Kyoto\u2013Kameoka Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051367"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rutherford, M., Downer, B., Li, C.-Y., and Al Snih, S. (2022). Body mass index and physical frailty among older Mexican Americans: Findings from an 18-year follow up. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0274290"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.clnu.2017.07.023","article-title":"Interrelations between body mass index, frailty, and clinical adverse events in older community-dwelling women: The EPIDOS cohort study","volume":"37","author":"Boutin","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12603-016-0854-3","article-title":"The Association between BMI and Different Frailty Domains: A U-Shaped Curve?","volume":"22","author":"Rietman","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: Implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jcsm.12268","article-title":"Pitfalls in the measurement of muscle mass: A need for a reference standard","volume":"9","author":"Buckinx","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jcsm.12195","article-title":"Muscle mass decline, arterial stiffness, white matter hyperintensity, and cognitive impairment: Japan Shimanami Health Promoting Program study","volume":"8","author":"Kohara","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/83.5.1142","article-title":"Frailty syndrome and skeletal muscle: Results from the Invecchiare in Chianti study","volume":"83","author":"Cesari","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/CIA.S243211","article-title":"Association Between Body Composition and Frailty in Elder Inpatients","volume":"15","author":"Xu","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"ref_53","first-page":"16","article-title":"Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Prell, T., Grimm, A., and Axer, H. (2024). Uncovering sarcopenia and frailty in older adults by using muscle ultrasound-A narrative review. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1333205"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bmb\/ldq008","article-title":"Sarcopenia: Characteristics, mechanisms and functional significance","volume":"95","author":"Narici","year":"2010","journal-title":"Br. Med. Bull."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/er.2012-1002","article-title":"Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?","volume":"33","author":"Giannoulis","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diab.30.12.1000","article-title":"The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization","volume":"30","author":"DeFronzo","year":"1981","journal-title":"Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-201x.1999.00573.x","article-title":"The impact of biochemical methods for single fiber analysis","volume":"166","author":"Pette","year":"1999","journal-title":"Acta Physiol. Scand."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E593","DOI":"10.1152\/ajpendo.1990.259.4.E593","article-title":"Glucose transporter protein content and glucose transport capacity in rat skeletal muscles","volume":"259","author":"Henriksen","year":"1990","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1532-5415.2010.03150.x","article-title":"Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men","volume":"58","author":"Verdijk","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/gerona\/glw253","article-title":"Extensive Type II Muscle Fiber Atrophy in Elderly Female Hip Fracture Patients","volume":"72","author":"Kramer","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1113\/JP278261","article-title":"Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women","volume":"597","author":"Sonjak","year":"2019","journal-title":"J. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcsm.12139","article-title":"The impact of ageing, physical activity, and pre-frailty on skeletal muscle phenotype, mitochondrial content, and intramyocellular lipids in men","volume":"8","author":"Pion","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ageing\/afx023","article-title":"Metabolic syndrome and insulin resistance are associated with frailty in older adults: A prospective cohort study","volume":"46","author":"Laclaustra","year":"2017","journal-title":"Age Ageing"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/jcsm.13516","article-title":"Long-term insulin resistance is associated with frailty, frailty progression, and cardiovascular disease","volume":"15","author":"Ke","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1038\/s41598-019-40902-1","article-title":"Association between HOMA-IR and Frailty among U. S. Middle-aged and Elderly Population","volume":"9","author":"Peng","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-025-02597-9","article-title":"Association between non-insulin-based insulin resistance indicators and frailty progression: A national cohort study and mendelian randomization analysis","volume":"24","author":"Tian","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., and Zheng, W. (2022). Macrophages, chronic inflammation, and insulin resistance. Cells, 11.","DOI":"10.3390\/cells11193001"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.exger.2009.08.008","article-title":"Frailty in the elderly is associated with insulin resistance of glucose metabolism in the postabsorptive state only in the presence of increased abdominal fat","volume":"44","author":"Goulet","year":"2009","journal-title":"Exp. Gerontol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/gerona\/glr141","article-title":"Frailty Status and Altered Glucose-Insulin Dynamics","volume":"67","author":"Kalyani","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.1142179","article-title":"Brain IRS2 signaling coordinates life span and nutrient homeostasis","volume":"317","author":"Taguchi","year":"2007","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diabet.2008.08.006","article-title":"Cardiometabolic determinants of mortality in a geriatric population: Is there a \u201creverse metabolic syndrome\u201d?","volume":"35","author":"Vischer","year":"2009","journal-title":"Diabetes Metab."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lu, Y., Lim, W.S., Jin, X., Zin Nyunt, M.S., Fulop, T., Gao, Q., Lim, S.C., Larbi, A., and Ng, T.P. (2022). Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults. Front. Med., 9.","DOI":"10.3389\/fmed.2022.971622"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Srikanthan, P., Hevener, A.L., and Karlamangla, A.S. (2010). Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: Findings from the National health and nutrition examination survey III. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010805"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.archger.2012.09.007","article-title":"Body composition and its association with cardiometabolic risk factors in the elderly: A focus on sarcopenic obesity","volume":"56","author":"Chung","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Abdelhafiz, A.H., Keegan, G.L., and Sinclair, A.J. (2023). Metabolic Characteristics of Frail Older People with Diabetes Mellitus-A Systematic Search for Phenotypes. Metabolites, 13.","DOI":"10.3390\/metabo13060705"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/ijcp.12455","article-title":"Can hypoglycaemic medications be withdrawn in older people with type 2 diabetes?","volume":"68","author":"Abdelhafiz","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"ref_78","first-page":"197","article-title":"Can diabetes medication be reduced in elderly patients? An observational study of diabetes drug withdrawal in nursing home patients with tight glycaemic control","volume":"82","author":"AndersTengblad","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ijcp.12796","article-title":"The emergence of frailty may burn out type 2 diabetes-a hypothesis","volume":"70","author":"Abdelhafiz","year":"2016","journal-title":"Int. J. Clin. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/JMDH.S194155","article-title":"Assessment of nutritional status in older diabetic outpatients and related factors in Hanoi, Vietnam","volume":"12","author":"Nguyen","year":"2019","journal-title":"J. Multidiscip. Heal."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3923\/pjbs.2014.1098.1105","article-title":"Nutritional status and cognitive impairment in elderly","volume":"17","author":"Daradkeh","year":"2014","journal-title":"Pak. J. Biol. Sci."},{"key":"ref_82","first-page":"75","article-title":"Impact of nutritional status on the evolution of Alzheimer\u2019s disease and on response to acetylcholinesterase inhibitor treatment","volume":"9","author":"Vellas","year":"2005","journal-title":"J. Nutr. Health Aging"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcjd.2018.06.001","article-title":"Frailty, Health-Related Quality of Life, Cognition, Depression, Vitamin D and Health-Care Utilization in an Ambulatory Adult Population with Type 1 or Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Cross-Sectional Analysis","volume":"43","author":"Senior","year":"2019","journal-title":"Can. J. Diabetes"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ggi.13637","article-title":"Combined effect of diabetes and frailty on mortality and incident disability in older Japanese adults","volume":"19","author":"Kitamura","year":"2019","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40200-020-00542-z","article-title":"Edmonton frail score is associated with diabetic control in elderly type 2 diabetic subjects","volume":"19","author":"Bilgin","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/jocn.15953","article-title":"Risk factors associated with frailty in older adults with type 2 diabetes: A cross-sectional study","volume":"31","author":"Lin","year":"2022","journal-title":"J. Clin. Nurs."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Wang, Z., Ma, B., Fan, L., Yi, N., Lu, B., Wang, Q., and Liu, R. (2018). GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01168"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Guo, C., Huang, T., Chen, A., Chen, X., Wang, L., Shen, F., and Gu, X. (2016). Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages. Braz. J. Med. Biol. Res., 49.","DOI":"10.1590\/1414-431x20165826"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"591056","DOI":"10.1155\/2013\/591056","article-title":"An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes","volume":"2013","author":"Puddu","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijmm.2017.2910","article-title":"Glucagon-Like Peptide 1 Receptor Agonist Ameliorates the Insulin Resistance Function of Islet Beta Cells Via the Activation of Pdx-1\/Jak Signaling Transduction in C57\/Bl6 Mice With High-Fat Diet-Induced Diabetes","volume":"39","author":"Hao","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00125-017-4303-6","article-title":"Glp-1 Signalling Compensates for Impaired Insulin Signalling in Regulating Beta Cell Proliferation in Betairko Mice","volume":"60","author":"Kawamori","year":"2017","journal-title":"Diabetologia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/db23-0356","article-title":"Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals With Obesity and Prediabetes","volume":"73","author":"Mashayekhi","year":"2024","journal-title":"Diabetes"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","article-title":"Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes","volume":"106","author":"Thomas","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Yan, H., Huang, C., Shen, X., Li, J., Zhou, S., and Li, W. (2022). GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.923606"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"156113","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"De La Flor, J.C., Coto Morales, B., Basabe, E., Rey Hernandez, M., Zamora Gonz\u00e1lez-Mari\u00f1o, R., Rodr\u00edguez Tudero, C., Benites Flores, I., Espinoza, C., Cieza Terrones, M., and Cigarr\u00e1n Guldris, S. (2024). Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure. Medicina, 60.","DOI":"10.3390\/medicina60122096"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Pan, R., Zhang, Y., Wang, R., Xu, Y., Ji, H., and Zhao, Y. (2022). Effect of SGLT-2 inhibitors on body composition in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0279889"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2017-01838","article-title":"Empagliflozin Treatment Is Associated With Improved Beta-Cell Function in Type 2 Diabetes Mellitus","volume":"103","author":"Daniele","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1187-P","DOI":"10.2337\/db18-1187-P","article-title":"Effects of SGLT2 Inhibitors on Insulin Secretion and Insulin Resistance\u2014Results from a Cross-Sectional Study","volume":"67","author":"Waseda","year":"2018","journal-title":"Diabetes"},{"key":"ref_100","first-page":"E214","article-title":"Glucose clamp technique: A method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am. J. Physiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/ageing\/afz096","article-title":"Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME trial","volume":"48","author":"Monteiro","year":"2019","journal-title":"Age Ageing"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/dc19-1476","article-title":"Efficacy and safety of dapagliflozin in the elderly: Analysis from the DECLARE-TIMI 58 Study","volume":"43","author":"Cahn","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Giugliano, D., Longo, M., Maiorino, M.I., Bellastella, G., Chiodini, P., Solerte, S.B., and Esposito, K. (2020). Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials. Diabetes Res. Clin. Pract., 108114.","DOI":"10.1016\/j.diabres.2020.108114"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/M18-1569","article-title":"Effect of liraglutide on cardiovascular outcomes in elderly patients: A post hoc analysis of a randomized controlled trial","volume":"170","author":"Gilbert","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/21548331.2021.1905414","article-title":"Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people","volume":"49","author":"Emmerton","year":"2021","journal-title":"Hosp. Pract."},{"key":"ref_107","unstructured":"(2025, April 30). International Diabetes Federation Global Guidelines for Managing Older People with Type 2 Diabetes. Available online: https:\/\/ifa.ngo\/wp-content\/uploads\/2014\/02\/IDF-Guideline-for-Older-People.pdf."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14283\/jfa.2017.39","article-title":"An international position statement on the management of frailty in diabetes mellitus: Summary of recommendations 2017","volume":"7","author":"Sinclair","year":"2018","journal-title":"J. Frailty Aging."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s40520-023-02519-3","article-title":"Essential steps in primary care management of older people with Type 2 diabetes: An executive summary on behalf of the European geriatric medicine society (EuGMS) and the European diabetes working party for older people (EDWPOP) collaboration","volume":"35","author":"Maggi","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_110","first-page":"14","article-title":"Diabetes Canada 2018 clinical practice guidelines: Key messages for family physicians caring for patients living with type 2 diabetes","volume":"65","author":"Ivers","year":"2019","journal-title":"Can. Fam. Physician"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13340-020-00439-5","article-title":"Japanese clinical practice guideline for diabetes 2019","volume":"11","author":"Araki","year":"2020","journal-title":"Diabetol. Int."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4093\/dmj.2024.0249","article-title":"2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association","volume":"48","author":"Moon","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2337\/dc23-0671","article-title":"Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes","volume":"46","author":"Kutz","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Sinclair, A.J., and Abdelhafiz, A.H. (2025). The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required. Metabolites, 15.","DOI":"10.3390\/metabo15010049"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jamda.2017.05.003","article-title":"Prevalence and Determinants of Poor Food Intake of Residents Living in Long-Term Care","volume":"18","author":"Keller","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Khoonin, W., Shantavasinkul, P.C., Santivarangkna, C., Praengam, K., and Trachootham, D. (2023). Eicosapentaenoic acid and branched-chain amino acids fortified complete nutrition drink improved muscle strength in older individuals with inadequate protein intake. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1164469"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"106396","DOI":"10.1016\/j.phrs.2022.106396","article-title":"SGLT2-inhibitors are effective and safe in the elderly: The SOLD study","volume":"183","author":"Lunati","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Rolek, B., Haber, M., Gajewska, M., Rogula, S., Pietrasik, A., and G\u0105secka, A. (2023). SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10080322"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Sohn, M., Nam, S., Nauck, M.A., and Lim, S. (2024). Long-term comparison of renal and metabolic outcomes after sodium\u2013glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC Med., 22.","DOI":"10.1186\/s12916-024-03483-z"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Li, C., Luo, J., Jiang, M., and Wang, K. (2022). The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.838277"},{"key":"ref_122","first-page":"e078242","article-title":"Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: Population based cohort study","volume":"385","author":"Treves","year":"2024","journal-title":"BMJ"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/dom.16078","article-title":"One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA","volume":"27","author":"Zhang","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/diabetology3020028","article-title":"Insulin in Frail, Older People with Type 2 Diabetes\u2014Low Threshold for Therapy","volume":"3","author":"Abdelhafiz","year":"2022","journal-title":"Diabetology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1111\/jgs.18360","article-title":"Adoption of sodium-glucose cotransporter-2 inhibitors among prescribers caring for nursing home residents","volume":"71","author":"Hayes","year":"2023","journal-title":"J. Am. Geriatr. Soc."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/6\/381\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:48:40Z","timestamp":1760032120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/6\/381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":125,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["metabo15060381"],"URL":"https:\/\/doi.org\/10.3390\/metabo15060381","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]}}}